Literature DB >> 21273128

Depot GnRH-agonist trigger for breast-cancer patient undergoing ovarian stimulation resulted in mature oocytes for cryopreservation: a case report.

Mario Cavagna1, Artur Dzik.   

Abstract

This report describes the case of a 27-year-old woman with breast cancer who underwent ovarian stimulation for fertility preservation with recombinant FSH in conjunction with a gonadotrophin-releasing hormone (GnRH) antagonist and an aromatase inhibitor from the beginning of the treatment. A 3.75-mg triptorelin depot formulation was given intramuscularly when the follicular diameter of three follicles reached ≥ 20 mm and a total of 13 follicles reached ≥ 15 mm. Oocyte retrieval was scheduled for 36 h later and 10 mature oocytes were collected and vitrified. This case report demonstrates that a depot GnRH-agonist trigger effectively leads to mature oocyte retrieval, with the advantage of initiating ovarian suppression for the purpose of fertility preservation during adjuvant chemotherapy in breast-cancer patients.
Copyright © 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21273128     DOI: 10.1016/j.rbmo.2010.11.015

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  4 in total

1.  Oncofertility in Canada: cryopreservation and alternative options for future parenthood.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

2.  Fertility preservation in reproductive-age women facing gonadotoxic treatments.

Authors:  J Roberts; R Ronn; N Tallon; H Holzer
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

Review 3.  GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).

Authors:  Raffaella Depalo; K Jayakrishan; Gabriella Garruti; Ilaria Totaro; Mariantonietta Panzarino; Francesco Giorgino; Luigi E Selvaggi
Journal:  Reprod Biol Endocrinol       Date:  2012-04-13       Impact factor: 5.211

4.  Efficacy of random-start controlled ovarian stimulation in cancer patients.

Authors:  Jee Hyun Kim; Seul Ki Kim; Hee Jun Lee; Jung Ryeol Lee; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  J Korean Med Sci       Date:  2015-02-16       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.